The increased rate of venous thromboembolism among patients with chronic kidney disease (CKD) warrants increased clinical attention.

For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities ...

Patients with gout living in rural vs urban areas face a significantly higher risk for MI-related hospitalization.

Individuals with Down syndrome are at increased risk of poor CV outcomes, including ischemic stroke and hemorrhagic stroke.

Adult-onset type 1 diabetes is associated with an increased risk for death and major adverse cardiovascular events.

Glucagon-like peptide-1 receptor agonists may cut the risk of obesity-related cancer in patients being treated for diabetes and obesity.

A scientific statement has been published by the AHA regarding palliative care and advanced cardiovascular disease in adults.

Hormone reset diets have taken off on social media as the latest weight loss trend, but their scientific validity remains questionable.

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

The FDA has approved Optison for use in pediatric patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricle endocardial borders.

A US study found a significantly higher cost of care associated with cirrhosis vs with heart failure or chronic obstructive pulmonary disease.

Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.